{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:32:05Z","timestamp":1790451125758,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.drugalcdep.2020.107994","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T21:07:10Z","timestamp":1587762430000},"page":"107994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review"],"prefix":"10.1016","volume":"212","author":[{"given":"Armando L.","family":"Morera-Fumero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Fernandez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.107994_bib0005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1360-0443.1987.tb01529.x","article-title":"Benzodiazepine Withdrawal: outcome in 50 patients","volume":"82","author":"Ashton","year":"1987","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/15622975.2015.1048725","article-title":"Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: a randomised, placebo-controlled, blinded trial","volume":"17","author":"Baandrup","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0015","first-page":"CD011481","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"2018","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0025","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits. A reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0030","first-page":"55","article-title":"A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly","volume":"23","author":"Cardinali","year":"2002","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0924-977X(96)00381-1","article-title":"Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report","volume":"7","author":"Dagan","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","author":"Downs","year":"1998","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0045","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0011-393X(97)80066-5","article-title":"Effects of melatonin in elderly patients with sleep disturbance: a pilot study","volume":"58","author":"Fainstein","year":"1997","journal-title":"Curr. Ther. Res. - Clin. Exp."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0050","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/archinte.159.20.2456","article-title":"Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach","volume":"159","author":"Garfinkel","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03324897","article-title":"Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Garzon","year":"2009","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0060","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0065","series-title":"The Oxford 2011 Levels of Evidence","author":"Howick","year":"2011"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0075","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/bcp.12294","article-title":"Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial","volume":"77","author":"L\u00e4hteenm\u00e4ki","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.pnpbp.2009.05.011","article-title":"Zaleplon increases nocturnal melatonin secretion in humans","volume":"33","author":"Morera","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1176\/appi.ajp.161.2.332","article-title":"Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia","volume":"161","author":"Morin","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brat.2003.12.002","article-title":"Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse","volume":"43","author":"Morin","year":"2005","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0100","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/070674371005501207","article-title":"Pharmacoepidemiology of Benzodiazepine and sedative-hypnotic use in a Canadian general population cohort during 12 years of follow-up","volume":"55","author":"Patten","year":"2010","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0105","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1360-0443.2007.02007.x","article-title":"Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-079X.2001.300105.x","article-title":"Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients","volume":"30","author":"Siegrist","year":"2001","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.aprim.2011.06.009","article-title":"Use of prescription drugs in Spain and Europe","volume":"44","author":"Sim\u00f3 Mi\u00f1ana","year":"2012","journal-title":"Aten. Primaria"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0125","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jclinepi.2006.11.024","article-title":"General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application","volume":"60","author":"Stewart","year":"2007","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0130","doi-asserted-by":"crossref","first-page":"107573","DOI":"10.1016\/j.drugalcdep.2019.107573","article-title":"Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: differences by insurance status","volume":"204","author":"Tardelli","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1192\/bjp.bp.113.134650","article-title":"Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care","volume":"204","author":"Vicens","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11096-007-9118-y","article-title":"Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial","volume":"29","author":"Vissers","year":"2007","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.drugalcdep.2020.107994_bib0145","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40266-015-0322-5","article-title":"The effect of melatonin on benzodiazepine discontinuation and sleep quality in adults attempting to discontinue benzodiazepines: a systematic review and meta-analysis","volume":"32","author":"Wright","year":"2015","journal-title":"Drugs Aging"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620301599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620301599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:09:06Z","timestamp":1759828146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620301599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"alternative-id":["S0376871620301599"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107994","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107994"}}